101
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Prevention of hypertensive disorders of pregnancy

Pages 123-126 | Published online: 02 Jul 2009

  • Beauills M., Uzan S., Donsimoni R. and Colau J. (1985) Prevention of pre-eclampsia by early antiplatelet therapy. Lancet, 1, 840-842.
  • Belizan J. and Villar J. (1980) The relationship between calcium intake and edema, proteinuria and hypertension--gestosis: a hypothesis. American Journal of Clinical Nutrition, 33, 2202--2210.
  • Belizan J., Millar J., Gonzalez L., Campodonico L. and Bergel E. (1991) Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine, 325, 1399-1405.
  • Bucher H. C., Guyart G. H., Cook R. J., Hatala R., Cook D. J., Lang J. D. and Hunt D. L. (1996) Effect of calcium supplementation on pregnancy-induced hypertension and pre-eclampsia. The Journal of the American Medical Association, 275, 1113-1117.
  • Carroli G., Duley L., Belizan J. and Villar J. (1994) Calcium supplementation during pregnancy: a systematic review of ;andomised controlled trials. British Journal of Obstetrics and Gynaecology, 101, 753-758.
  • CLASP Collaborative Group (1994) CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet, 343, 619-629.
  • Collins E. and Turner G. (1975) Maternal effects of regular salicylate ingestion in pregnancy. Lancet, 2, 335-339.
  • Davies N. (1992) Hypertensive disorders of pregnancy for the trainec. British Journal of Hospital Medicine, 47, 613-619.
  • Friedman S. (1988) Pre-eclampsia: a review of the role of prostaglandins. Obstetrics and Gynecology, 71, 122-137.
  • Kaunitz A., Hughes J., Grimes D., Smith J. Rochat R. W. and Kafrissen M. E. (1985) Causes of maternal mortality in the United States. Obstetrics and Gynecology, 65, 605-612.
  • Levine R. J., Hauth J. C., Curet L. B., Sibai B. M., Catalano P.M., Morris C. D., Der Simonian R., Esterlitz J. R., Raymond E.G., Bild D., Clemens J. D. and Cutler J. A. (1997) Trial of calcium to prevent pre-eclampsia. The New England Journal of Medicine, 337, 69-76.
  • Long P. A., Abell D. A. and Beischer N. (1980) Fetal growth retardation and pre-eclampsia. British Journal of Obstetrics and Gynaecology, 87, 13-18.
  • Lopez-Jaramillo P., Narvaez M., Weigel M. and Yepez R. (1989) Calcium supplementation reduces the risk of pregnancy-induced hypertension in the Andes population. British Journal of Obstetrics and Gynaecology, 96, 648-655.
  • Lopez-Jaramillo P. and Felix M. (1991) Prevention of toxemia of pregnancy in Ecuadorian Andean women: experience with dietary calcium supplementation. Bulletin PAHO, 25, 109-117.
  • Masotti G., Galanti G., Poggesi L., Abbate R. and NeriSerneri G. (1979) Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet, 2, 1213-1217.
  • McParland P., Pearce J. and Chamberlain G. (1990) Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet, 1, 1552-1555.
  • Page E. W. and Christianson R. (1976) The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. American Journal of Obstetrics and Gynecology, 125, 740-746.
  • Pang P. (1992) Satellite symposium of the International Society of Hypertension on the parathyroid hypertensive factc,r. Journal of Cardiovascular Pharmacology (special :issue).
  • Pipkin F. B., Crowther C., de Swiet M., Duley L., Judd A., Lilfc,rd R., Onwude J., Prentice C., Redman C. W., Roberts J., Thornton J. and Walker J. (1996) Where next for prophylaxis against pre-eclampsia? British Journal of Obstetrics and Gynaecology, 103, 603-607.
  • Repke J. and Villar J. (1991) Pregnancy-induced hypertension and low birthweight: the role of calcium. American Journal of Clinical Nutrition, 54, 237S-241S.
  • Roopnarinesingh S., Ramoutar P. and Bassaw B. (1991) Maternal mortality at Mount Hope Women's Hospital, Trimdad. West Indian Medical Journal, 40, 139-141.
  • Schiff E., Peleg E., Goldenberg M., Rosenthal T., Ruppin E., Tamarkin M., B~rkai G., Ben-Baruch G., Yahal I., Blankstein J., Goldman B. and Mashiach S. (1989) The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. New England Journal of Medicine, 321, 351-356.
  • Sibai B., Mirro R., Chesney C. and Leffler C. (1989) Low-dose aspirin in pregnancy. Obstetrics and Gynecology, 74, 551-557.
  • Sullivan J. M. (1986) Hypertension and Pregnancy, pp. 3-7. Chicago, Year Book Medical Publishers.
  • Uzan S., Beauills M., Breart G., Bazin B., Capitant C. and Paris J. (1991) Prevention of fetal growth retardation with low dose aspirin: findings of the EPREDAL trial. Lancet, 337, 1427-1431.
  • Wallenburg H. C., Dekker G. A., Makovitz J. W. and Rotroans P. (1986) Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet, 1, 1-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.